Skip to content

A Photoplethysmography-Based Machine Learning Algorithm for Early Atrial Fibrillation Detection: A Prospective Validation Study

Prospective Validation of a Machine-Learning Algorithm Using Photoplethysmography Signals for Early Detection of Atrial Fibrillation During Remote Telemonitoring

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07749183
Acronym
HeartCore AF
Enrollment
200
Registered
2026-08-06
Start date
2025-10-01
Completion date
2026-11-01
Last updated
2026-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation (AF), Heart Failure

Keywords

Photoplethysmography, Machine learning, Remote telemonitoring, Wearable device, Digital biomarker, Arrhythmia detection

Brief summary

This is a prospective study validating a new machine-learning algorithm that detects atrial fibrillation (AF) from photoplethysmography (PPG) signals, developed for integration into the Seerlinq remote monitoring platform. This algorithm builds on the same core PPG signal-processing technology as Seerlinq's HeartCore device, a CE-certified (Class IIb, MDR) device that monitors left ventricular filling pressures in heart failure patients. The algorithm will be validated through internal cross-validation, external validation against an independent cohort with paired PPG-ECG recordings, and validation in a cohort of patients with paroxysmal atrial fibrillation and frequent sinus-AF transitions.

Detailed description

Atrial fibrillation (AF) and heart failure (HF) frequently coexist and share a bidirectional causal relationship; their concurrence is associated with worse clinical outcomes. Early detection of AF may enable timely intervention and improve outcomes. This study is prospectively validating a machine-learning algorithm for AF detection from PPG signals, intended for integration into the Seerlinq remote monitoring platform. This algorithm builds on the same core PPG signal-processing technology as Seerlinq's HeartCore device (a CE-certified, Class IIb device under the EU MDR that monitors left ventricular filling pressures in heart failure patients). It is a stand-alone algorithm designed specifically to detect clinically relevant (≥ 30s) atrial fibrillation. Validation of the algorithm will proceed in three stages: (1) internal cross-validation; (2) external validation against an independent cohort with paired PPG-ECG recordings, to confirm generalizability; and (3) validation in a cohort of patients with paroxysmal atrial fibrillation and frequent sinus-AF transitions, to assess performance during clinically challenging rhythm changes. The study is enrolling toward an estimated 1,000 unique PPG recordings. A 12-lead ECG is used to confirm cardiac rhythm classification (gold standard) as the reference for evaluating algorithm performance.

Interventions

OTHERPPG-based AF detection algorithm

The PPG-based atrial fibrillation detection algorithm is a non-invasive signal processing approach that analyzes photoplethysmographic waveforms obtained during remote monitoring. The algorithm evaluates pulse-to-pulse variability, waveform characteristics, and signal quality parameters to identify irregular rhythm patterns associated with atrial fibrillation and provide early detection of potential arrhythmic events.

Sponsors

Seerlinq s. r. o.
Lead SponsorOTHER
ACADEMY - občianske združenie
CollaboratorUNKNOWN
Premedix Academy
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults ≥18 years with a diagnosis of heart failure (HFrEF, HFmrEF, or HFpEF) * 12-lead ECG performed to confirm cardiac rhythm classification (AF vs. non-AF)

Exclusion criteria

* Missing a valid PPG recording

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy (area under the ROC curve) of the PPG-based machine-learning algorithm for detecting clinically relevant AF (≥ 30s), compared with gold-standard 12-lead ECGThrough study completion (estimated November 2026)

Secondary

MeasureTime frameDescription
Sensitivity and specificity of the algorithm at the Youden-optimal thresholdThrough study completion (estimated November 2026)
Positive predictive value and negative predictive valueThrough study completion (estimated November 2026)
Average precisionThrough study completion (estimated November 2026)area under the precision-recall curve
Model calibrationThrough study completion (estimated November 2026)e.g., calibration curve / Brier score
Matthews correlation coefficientThrough study completion (estimated November 2026)
Overall classification accuracyThrough study completion (estimated November 2026)
Specificity and false-positive rate in the subgroup with frequent atrial/ventricular extrasystolesThrough study completion (estimated November 2026)
Accuracy of AF detection during sinus-AF transitions at the individual patient levelThrough study completion (estimated November 2026)

Countries

Slovakia

Contacts

CONTACTMarta Kollárová, MSc., PhD.
marta.kollarova@premedix.org+421 950 896 026

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 7, 2026